HCW Biologics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of HCW Biologics generated cash of -$22,514,121, which is less than the previous year. Cash used in financing activities reached the amount of -$14,534 last year. Net change in cash is therefore -$18,731,255.
Cash Flow
| 2019 | -6.76M | -1.46M | 13.44M |
|---|---|---|---|
| 2020 | -10.43M | -186.68K | 11.71M |
| 2021 | -10.97M | -35.01M | 49.26M |
| 2022 | -10.38M | 14.70M | 6.27M |
| 2023 | -22.51M | 3.79M | -14.53K |
HCWB Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 22.32M | 11.73M | 8.45M | 7.35M | 2.13M |
Operating activities | |||||
Net income | -24.99M | -14.90M | -12.86M | -5.80M | -7.29M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.13M | 717.85K | 543.59K | 595.91K | 421.81K |
Stock-based compensation expense | 1.00M | 1.12M | 360.97K | 21.87K | 1.76K |
| Deferred income tax benefit | 1.00M | 1.12M | 360.97K | 21.87K | 1.76K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -1.11M | -284.69K | 2.36M | -2.5M | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.61M | 418.20K | 1.88M | -628.64K | 766.39K |
Cash generated by operating activities | -22.51M | -10.38M | -10.97M | -10.43M | -6.76M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | -34.97M | 0 | 0 |
Investments In Property Plant And Equipment | -6.20M | -10.27M | -47.26K | -186.68K | -1.46M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 3.79M | 14.70M | -35.01M | -186.68K | -1.46M |
Financing activities | |||||
Common Stock Issued | 23.73K | 15.77K | 56.02M | 9.89K | 60.28K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -38.27K | 6.44M | 0 | -563.59K | 0 |
Cash used in financing activities | -14.53K | 6.27M | 49.26M | 11.71M | 13.44M |
Net Change In Cash | -18.73M | 10.59M | 3.27M | 1.1M | 5.22M |
Cash at end of period | 3.59M | 22.32M | 11.73M | 8.45M | 7.35M |
| Data source | Data source | Data source |